2022 annual financial data
Kyverna Therapeutics 2022 Operating margin
Direct answer
Operating margin was -418.28%.
Operating income was -29,384,000 USD and net income was -28,893,000 USD.
Operating cash flow was -36,113,000 USD.
Get free Kyverna Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 7,025,000 USD
- Operating income
- -29,384,000 USD
- Net income
- -28,893,000 USD
- Operating cash flow
- -36,113,000 USD